Classification of multiple sclerosis clinical forms by 1H magnetic ressonance spectroscopy of cerebrospinal fluid

Postprint (published version

Assessment of automatic decision-support systems for detecting active T2 lesions in multiple sclerosis patients

Active (new/enlarging) T2 lesion counts are routinely used in the clinical management of multiple sclerosis. Thus, automated tools able to accurately identify active T2 lesions would be of high interest to neuroradiologists for assisting in their clinical activity. To compare the accuracy in detecting active T2 lesions and of radiologically active patients based on different visual and automated methods.Postprint (author's final draft

Classification of multiple sclerosis clinical forms by 1H magnetic ressonance spectroscopy of cerebrospinal fluid

Postprint (published version

Unstructured multigrid methods First experiences

SIGLEAvailable from British Library Lending Division - LD:9106.966(C/R--518/85) / BLDSC - British Library Document Supply CentreGBUnited Kingdo

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis

Inflammation and neurodegeneration may have differential impacts on disease evolution in the different forms of multiple sclerosis. However, a beneficial effect of immunomodulatory drugs should not be ruled out in primary progressive multiple sclerosis. Our aim is to investigate the safety and efficacy of interferon beta-1b in primary progressive multiple sclerosis. We conducted a double-blind, stratified, randomized, parallel group, phase II pilot study where patients with primary progressive multiple sclerosis or ‘transitional’ forms of multiple sclerosis received interferon beta-1b at doses of 8 MIU or placebo for 24 months. The main objective of the study was to investigate the safety and tolerability of interferon beta-1b. The primary efficacy variable was the time to neurological deterioration (Expanded Disability Status Scale) confirmed at 3 months. Seventy-three patients were included and three dropped out the study. More patients in the treatment arm had at least one related adverse event (94.4% versus 45.9%; p<0.001); no other significant differences in safety endpoints were observed. Time to neurological deterioration was not different between trial arms (log-rank test, p¼0.3135). Statistically significant differences favoring treatment were observed for the Multiple Sclerosis Functional Composite score at several timepoints, T1 and T2 lesion volume changes at 12 and 24 months, mean number of active lesions and proportion of patients with active lesions at 24 months. We conclude that interferon beta-1b is safe and well tolerated in patients with primary progressive multiple sclerosis and transitional multiple sclerosis. Positive effects of interferon beta on secondary clinical and magnetic resonance imaging outcomes were observed, but a beneficial effect on Expanded Disability Status Scale progression was not demonstrated.Peer Reviewe

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis

Inflammation and neurodegeneration may have differential impacts on disease evolution in the different forms of multiple sclerosis. However, a beneficial effect of immunomodulatory drugs should not be ruled out in primary progressive multiple sclerosis. Our aim is to investigate the safety and efficacy of interferon beta-1b in primary progressive multiple sclerosis. We conducted a double-blind, stratified, randomized, parallel group, phase II pilot study where patients with primary progressive multiple sclerosis or ‘transitional’ forms of multiple sclerosis received interferon beta-1b at doses of 8 MIU or placebo for 24 months. The main objective of the study was to investigate the safety and tolerability of interferon beta-1b. The primary efficacy variable was the time to neurological deterioration (Expanded Disability Status Scale) confirmed at 3 months. Seventy-three patients were included and three dropped out the study. More patients in the treatment arm had at least one related adverse event (94.4% versus 45.9%; p<0.001); no other significant differences in safety endpoints were observed. Time to neurological deterioration was not different between trial arms (log-rank test, p¼0.3135). Statistically significant differences favoring treatment were observed for the Multiple Sclerosis Functional Composite score at several timepoints, T1 and T2 lesion volume changes at 12 and 24 months, mean number of active lesions and proportion of patients with active lesions at 24 months. We conclude that interferon beta-1b is safe and well tolerated in patients with primary progressive multiple sclerosis and transitional multiple sclerosis. Positive effects of interferon beta on secondary clinical and magnetic resonance imaging outcomes were observed, but a beneficial effect on Expanded Disability Status Scale progression was not demonstrated.Peer Reviewe

Measures in the first year of therapy predict the response to interferon beta in MS

Several criteria for treatment response to interferon beta (IFNβ) have been proposed, although there is no consensus among different investigators. Hence, the aim of this study was to investigate magnetic resonance imaging (MRI) and clinical predictors of response during the first 12 months of therapy.Peer Reviewe

General patterns of circulation, sediment fluxes and ecology of the Palamós (La Fonera) submarine canyon, northwestern Mediterranean

Currents, particle fluxes and ecology were studied in the Palamós submarine canyon (also known as the Fonera canyon), located in the northwestern Mediterranean. Seven mooring arrays equipped with current meters and sediment traps were deployed along the main canyon axis, on the canyon walls and on the adjacent slope. Additionally, local and regional hydrographic cruises were carried out. Current data showed that mean near surface and mid-depth currents were oriented along the mean flow direction (NE-SW), although at 400 and 1200 m depth within the canyon current reversals were significant, indicating a more closed circulation inside the canyon. Mean near-bottom currents were constrained by the local bathymetry, especially at the canyon head. The most significant frequency at all levels was the inertial frequency. A second frequency of about three days, attributed to a topographic wave, was observed at all depths, suggesting that this wave was probably not trapped near the bottom. The current field observed during the most complete survey revealed a meandering pattern with cyclonic vorticity just upstream from and within the canyon. The associated vertical velocity ranged between 10 and 20 m/day and was constrained to the upper 300 m. This latter feature, together with other computations, suggests that during this survey the meander was not induced by the canyon but by some kind of instability of the mean flow. In the canyon, suspended sediment concentration, downward particle fluxes, chlorophyll and particulate C and N were significantly higher up-canyon from about 1200 m depth than offshore, defining, along with the different hydrodynamics, two canyon domains: one from the canyon head to about 1200 m depth more affected by the canyon confinement and the other deeper than 1200 m depth more controlled by the mean flow and the shelf-slope front. The higher near-bottom downward total mass fluxes were recorded in the canyon axis at 1200 m depth along with sharp turbidity increases and are related to sediment gravity flows. During the deployment period, the increase in downward particle fluxes occurred by mid-November, when a severe storm took place. On the canyon walls at 1200 m depth, suspended sediment concentrations, downward particle fluxes, chlorophyll and particulate C and N were higher on the southern wall than on the northern wall inversely to the current's energy. This could be caused by an upward water supply on the southern canyon wall and/or the mean flow interacting with the canyon bathymetry. In the swimmers collected by the sediment traps, the dominant species was an elasipod holothurian, which has not been recorded in other canyons or elsewhere in the Mediterranean, indicating particular speciation. © 2005 Elsevier Ltd. All rights reserved.Peer Reviewe